Evidence map›Paper›PMID 36039582›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2022

Diagnostic efficiency of metagenomic next-generation sequencing on spinal infection and prognosis.

Chaofeng Guo, Guang Zhang, Xiaojiang Hu, Dongcheng Xu, Bo Tang, Hongqi Zhang, Mingxing Tang, Shaohua Liu, Yanbing Li, Qile Gao

Open access · greenAbstract read
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chaofeng GuoDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008. 343942471@qq.com.
Guang ZhangDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008.
Xiaojiang HuDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008.
Dongcheng XuDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008.
Bo TangDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008.
Hongqi ZhangDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008.
Mingxing TangDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008.
Shaohua LiuDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008.
Yanbing LiNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha 410008.
Qile GaoDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008. gaoql@csu.edu.cn.
Xiangya Hospital Central South University · CN

Funding

the National Natural Science Foundation 82072460 and 82170901the Natural Science Foundation of Hunan Province 2020JJ4892 and 2020JJ4808
6 · The paper itself

Abstract

objectivesSpinal infection is a rare infectious disease that is difficult to treat. The incidence of spinal infection is on the rise with the experiential use of antibiotics, the increasing incidence of drug-resistant bacteria, and the improvement of detection techniques. Traditional detection methods have limitations such as low sensitivity and long time-consuming in the diagnosis of spinal infection. In the clinical diagnosis and treatment of spinal infection, it has always been the focus and difficulty to determine the type of pathogens and to use antibiotics in a targeted manner. Many patients in the early stage of spinal infection due to the limitations of traditional detection methods cannot be quickly and accurately diagnosed, resulting in diagnosis delay, missed the best treatment time, bringing disastrous consequences to patients. There is an urgent need for a high-specificity, high-sensitivity, and time-saving test technique in clinical practice, which can simultaneously distinguish and identify the pathogen of spinal infection. Metagenomic next-generation sequencing (mNGS) is a new frontier technology emerging in recent years. It can detect all known pathogens in samples and has been used to diagnose clinically atypical and rare infectious diseases. This study aims to analyze the sensitivity of mNGS technique in diagnosing pathogens after spinal infection and its effect on prognosis.

methodsClinical data of 82 patients with spinal infection admitted to Xiangya Hospital of Central South University from January 2019 to December 2021 were retrospectively analyzed. Peripheral blood erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and procalcitonin (PCT) were routinely performed before surgery, and focal tissue specimens were obtained during surgery. Microbial culture, histopathological examination, and mNGS detection were performed. All patients were assigned into a targeted medication group (

resultsThe positive rate of mNGS (86.59%, 71/82) was significantly higher than that of microbial culture (18.99%, 15/79) and PCT (30.23%, 13/43). There were no significant differences in preoperative temperature, white blood cell count, neutrophil ratio, and scores of Visual Analogue Scale between the targeted medication group and the experienced treatment group. Preoperative use of antibiotics had no significant effect on the positive rate of mNGS and microbial culture (

conclusionsCompared with the microbial culture or PCT, mNGS has a higher sensitivity rate to detect pathogens of spinal infection. Patients receiving targeted antibiotics based on the results of mNGS have better outcomes than those receiving the experienced medicine.

Indexed as

Anti-Bacterial AgentsHigh-Throughput Nucleotide SequencingHumansPrognosisRetrospective StudiesSensitivity and SpecificityAnti-Bacterial Agentsdiagnosismetagenomic next-generation sequencingprognosisspondylitis

Identifiers

PMID36039582
PMCPMC10930291
OpenAlexW4293680556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.